Biocept Inc. buy stratec
Start price
26.03.19
/
50%
€300.36
Target price
04.11.21
€811.80
Performance (%)
-65.44%
End price
05.11.21
€103.80
Summary
This prediction ended on 05.11.21 with a price of €103.80. Massive losses of -65.44% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Biocept Inc. | - | - | - | - |
iShares Core DAX® | 1.164% | 1.549% | 24.351% | 23.659% |
iShares Nasdaq 100 | 0.118% | 0.969% | 28.865% | 41.786% |
iShares Nikkei 225® | 1.124% | -1.120% | 17.443% | 6.454% |
iShares S&P 500 | 0.479% | 1.068% | 28.585% | 42.511% |
Comments by stratec for this prediction
In the thread Biocept Inc. diskutieren
stratec stimmt dem Sentiment von 'Buy' zu
Biocept’s Target Selector is a liquid biopsy platform which, in addition to providing actionable data based on circulating tumor DNA (ctDNA) analysis, incorporates circulating tumor cell (NYSE:CTC) analysis which differentiates the company in an increasingly ‘crowded’ liquid biopsy space.”
In the thread Trading Biocept Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten